Showing results (61-70 of 147) with videos related to
Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|December 20, 2025
Bridging the gap in lung cancer: A comprehensive global strategy for changeKostas N Syrigos, Mary E Bussell, Humaid O Al-Shamsi, et al.The Journal of Thoracic and Cardiovascular Surgery|September 3, 2017
Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinomaRebecca W Gao, Mark F Berry, Christian A Kunder, et al.Clinical Lung Cancer|May 27, 2008
Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?Corey J Langer, Heather Wakelee, Joan Schiller, et al.Oncoimmunology|October 26, 2020
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinomaAlexandra Drakaki, Preet K Dhillon, Heather Wakelee, et al.JCO Clinical Cancer Informatics|July 15, 2021
Machine Learning Radiomics Model for Early Identification of Small-Cell Lung Cancer on Computed Tomography ScansRajesh P Shah, Heather M Selby, Pritam Mukherjee, et al.Cancer Chemotherapy and Pharmacology|July 22, 2018
A safety, tolerability, and pharmacokinetic analysis of two phase I studies of multitargeted small molecule tyrosine kinase inhibitor XL647 with an intermittent and continuous dosing schedule in patients with advanced solid malignanciesMillie Das, Sukhmani K Padda, Adam Frymoyer, et al.Clinical Lung Cancer|May 16, 2018
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung CancerAlexander L Chin, Kiran A Kumar, Haiwei H Guo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumorsQuynh-Thu Le, Billy W Loo, Anthony Ho, et al.Future Oncology (London, England)|November 14, 2025
Osimertinib before and after chemoradiotherapy for unresectable stage III EGFR-mutated NSCLC: NEOLA Trial ProtocolJacqueline V Aredo, Nir Peled, Edurne Arriola, et al.Clinical Lung Cancer|December 17, 2008
Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancerHeather Wakelee, Kemp Kernstine, Everett Vokes, et al.Pageof 15